{
  "Variants Include": [
    {
      "Gene": "PINK1",
      "variants": [
        {
          "HGVS": "NM_004561.3:c.1310G>A (standardized via API)",
          "cDNA Change": {
            "transcript": "NM_004561.3",
            "ref": "G",
            "alt": "A",
            "position": "1310"
          },
          "Protein Change": {
            "ref": "W",
            "alt": "X",
            "position": "437"
          },
          "Description in input context": "homozygous W437X nonsense mutation"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Early-onset Parkinsonism",
    "MONDO": "MONDO:0005148"
  },
  "Experiment Method": [
    {
      "Assay Method": "Mitochondrial Respiration Analysis",
      "Material used": {
        "Material Source": "Patient-derived fibroblasts",
        "Material Name": "Early-onset Parkinsonism patient fibroblasts",
        "Description": "Fibroblasts from a patient with early-onset Parkinsonism and normal fibroblasts were compared."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_004561.3:c.1310G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Loss of PINK1 function leading to mitochondrial dysfunction",
          "Result Description": "Lower respiratory activity and decreased respiratory control ratio in patient fibroblasts compared to normal controls."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not described in the literature"
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not described in the literature"
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Normal fibroblasts used as control"
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not described in the literature"
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Respiratory activity and control ratio within reference ranges for healthy fibroblasts",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Respiratory activity and control ratio below reference ranges for healthy fibroblasts",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Cytochrome c Content Measurement",
      "Material used": {
        "Material Source": "Patient-derived fibroblasts",
        "Material Name": "Early-onset Parkinsonism patient fibroblasts",
        "Description": "Cytochrome c levels were quantified in patient and normal fibroblasts."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_004561.3:c.1310G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Reduced cytochrome c content",
          "Result Description": "Decreased cytochrome c content in patient fibroblasts compared to normal controls."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not described in the literature"
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not described in the literature"
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Normal fibroblasts used as control"
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not described in the literature"
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Cytochrome c levels within reference ranges for healthy fibroblasts",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Cytochrome c levels below reference ranges for healthy fibroblasts",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "ROS Production Assay",
      "Material used": {
        "Material Source": "Patient-derived fibroblasts",
        "Material Name": "Early-onset Parkinsonism patient fibroblasts",
        "Description": "ROS levels (O2•- and H2O2) were measured in patient and normal fibroblasts."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_004561.3:c.1310G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Increased oxidative stress",
          "Result Description": "Elevated O2•- and H2O2 production in patient fibroblasts compared to normal controls."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not described in the literature"
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not described in the literature"
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Normal fibroblasts used as control"
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not described in the literature"
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "ROS levels within reference ranges for healthy fibroblasts",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "ROS levels above reference ranges for healthy fibroblasts",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Glutathione Redox Buffering Assay",
      "Material used": {
        "Material Source": "Patient-derived fibroblasts",
        "Material Name": "Early-onset Parkinsonism patient fibroblasts",
        "Description": "Glutathione redox buffering capacity was assessed in patient and normal fibroblasts."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_004561.3:c.1310G>A",
          "Conclusion": "Normal",
          "Molecular Effect": "No significant change in glutathione redox buffering",
          "Result Description": "Glutathione redox buffering capacity was normal in patient fibroblasts compared to controls."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not described in the literature"
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not described in the literature"
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Normal fibroblasts used as control"
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not described in the literature"
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Glutathione redox buffering within reference ranges for healthy fibroblasts",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Glutathione redox buffering outside reference ranges for healthy fibroblasts",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}